logo
Wuhan Desheng Biochemical Technology Co., Ltd
Wuhan Desheng Biochemical Technology Co., Ltd
News
Home / News /

Company News About Five indicators for measuring the quality of coagulants

Five indicators for measuring the quality of coagulants

2026-06-08
Five indicators for measuring the quality of coagulants

Blood coagulants are the core components in blood collection vessels that accelerate blood coagulation, and their performance directly affects the efficiency of serum separation and the accuracy of subsequent testing. Evaluating the suitability of a coagulant should not only focus on its coagulation speed, but also comprehensively consider five aspects: coagulation time, coagulation efficiency, coagulation effect, separation effect, and its impact on blood components. These five dimensions are interrelated and together determine the actual use value of the product.


Coagulation time and efficiency


The coagulation time refers to the time required for blood to completely coagulate after coming into contact with a coagulant, which is the most intuitive performance indicator. The shorter the time, the faster the coagulation process starts, and the shorter the sample processing cycle. For emergency testing scenarios that require rapid reporting, differences in coagulation time can directly affect work efficiency.


The coagulation efficiency focuses on the relative amount of coagulant required to achieve the optimal coagulation effect. Efficient coagulants can achieve ideal solidification speed with minimal addition. This not only reduces the cost of raw materials, but also minimizes the interference of foreign components on blood samples. The coagulation time and efficiency need to be considered in combination: some products require a large amount of addition to achieve rapid coagulation, while others can achieve the same effect with a small amount of addition, and the comprehensive advantages of the latter are more obvious.


Condensation effect and separation effect


The coagulation effect mainly tests the amount of serum leakage after blood coagulation. After complete coagulation of blood, a blood clot will form, and when the clot contracts, it will squeeze out the serum. A coagulant with good coagulation effect can cause blood clots to fully contract, resulting in a large and rapid amount of serum leakage, thereby increasing the serum yield per unit volume of blood. If the coagulation effect is poor, the serum will be wrapped in loose blood clots and cannot be effectively separated, resulting in sample waste.


The separation effect is a comprehensive reflection of the performance of coagulants. After coagulation, the blood needs to be centrifuged to achieve complete serum separation and clear interface. The ideal separation effect is a clear and transparent serum layer, a dense and intact blood clot layer, a clear boundary between the two, and no hemolysis phenomenon. Hemolysis refers to the rupture of red blood cells leading to the release of hemoglobin into the serum, which can cause the serum to appear red and interfere with the detection of multiple biochemical indicators. When evaluating the separation effect, it is necessary to carefully observe whether the serum color is normal and whether the interface is smooth.


The impact on essential components of blood


This is the most easily overlooked but equally important evaluation dimension. The use of coagulants should not have harmful effects on the clinical test results of blood and the performance quality of blood products. This means that coagulants and their products after reacting with blood should not interfere with the accuracy of subsequent testing results. For example, certain coagulants may affect electrolyte determination, enzyme activity testing, or hormone immunoassay. When evaluating a coagulant, it is necessary to confirm that its interference level with common clinical testing items is within an acceptable range. For scenarios used in the production of blood products, it is also necessary to investigate whether residual coagulants affect the quality and safety of the products.


Hubei Xindesheng Material Technology Co., Ltd. specializes in the production of blood collection tube additives such as coagulants. With a professional technical team, we can provide customers with detailed product quality inspection reports to ensure that every parameter indicator of the product meets relevant standards. If you have any recent purchasing needs, please click on the official website to learn more details or contact me directly!